Evidence map›Paper›PMID 41737010›Full record

ArticleFrontiers in pharmacology2025

Characterization and anti-inflammatory studies of supramolecular assemblies of chlorogenic acids with metal ions.

Zhen-Min Zhang, Ru-Yue Zhang, Lian Zhu, Zi-Xuan Liu, Han-Xiu Deng, Jie-Fu Tang, Jia-Yu Zhang, Wei Cai

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhen-Min Zhang *School of Pharmacy, Binzhou Medical University, Yantai, Shandong, China.
Ru-Yue Zhang *School of Pharmacy, Binzhou Medical University, Yantai, Shandong, China.
Lian Zhu *School of Pharmacy, Hunan University of Medicine, Huaihua, Hunan, China.
Zi-Xuan LiuSchool of Pharmacy, Hunan University of Medicine, Huaihua, Hunan, China.
Han-Xiu DengSchool of Pharmacy, Binzhou Medical University, Yantai, Shandong, China.
Jie-Fu TangThe First Affiliated Hospital of Hunan University of Medicine, Huaihua, Hunan, China.
Jia-Yu ZhangSchool of Pharmacy, Binzhou Medical University, Yantai, Shandong, China.
Wei CaiSchool of Pharmacy, Hunan University of Medicine, Huaihua, Hunan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Self-assembled natural small molecules are believed to have numerous potential applications, particularly in the material and pharmaceutical industries, as self-assembly increases the anti-inflammatory, antitumor, antiviral, and other biological activities. In this study, we synthesized more potent potential anti-inflammatory agents by combining chlorogenic acids with metals (iron and copper). Methods: Supramolecular assemblies were synthesized by combining chlorogenic acids with iron and copper. The synthesis conditions were optimized using mass spectrometry. The resulting complexes were comprehensively characterized by ultraviolet-visible spectroscopy, Fourier-transform infrared spectroscopy, and mass spectrometry to confirm their formation and stoichiometry. The anti-inflammatory activity was evaluated in vitro using lipopolysaccharide-induced RAW264.7 macrophages. The production of inflammatory mediators (NO, IL-6, IL-1β, TNF-α) was measured. Mechanistic studies were conducted to assess the effects on the NF-κB signaling pathway and the expression of downstream proteins iNOS and COX-2. Results: Characterization data confirmed the successful formation of chlorogenic acid-metal supramolecules, primarily in a 1:1 stoichiometry. These metal-based complexes exhibited significantly enhanced anti-inflammatory effects compared to the parent chlorogenic acid molecules. Discussion: The findings confirm that complexation with metals (iron and copper) successfully enhances the anti-inflammatory efficacy of chlorogenic acids. The primary mechanism involves the inhibition of the NF-κB pathway. This study provides a novel and efficient strategy for augmenting the bioactivities of natural products and highlights the considerable potential of chlorogenic acid-metal supramolecular assemblies as a promising new class of anti-inflammatory agents.

Indexed as

anti-inflammationchlorogenic acidsmetal ionsNF-κB signaling pathwaysupramolecular assemblies

Identifiers

PMID41737010
PMCPMC12926475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.